The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
September 8, 2014
Back to Press Releases
Vaccines have always been controversial, but never more so than in the last 15 years. The late 1990s saw the vaccine-autism scare and the mercury-based preservative, thimerosal, scare—both of which helped vaccine critics portray vaccines as unsafe. While it was a period characterized by low levels of vaccine-preventable diseases, it was also a time of high levels of organized interest-group activity opposing vaccine mandates, much doubt about vaccine safety among parents, and greater use of exemptions to avoid or delay vaccination. Vaccine critics and activists were able to pass legislation in their favor. How are vaccine critics doing now? How has their ability to affect legislation changed over time? A study in The Milbank Quarterly has found that recent events—such as the discrediting of the vaccine-autism link and outbreaks of whooping cough—have slowed the gains made by vaccine critics at the state level.